The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.50 (1.22%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bosch collaboration with Fieldwork

6 Jul 2020 07:00

RNS Number : 0287S
Frontier IP Group plc
06 July 2020
 

RNS Reach

AIM: FIPP

06 July 2020

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Bosch UK to work with Fieldwork Robotics to optimise robot crop harvesting technology

 

Frontier IP, a specialist in commercialising intellectual property, today announces that Robert Bosch Limited ("Bosch") has entered into an agreement to work with portfolio company Fieldwork Robotics ("Fieldwork" or the "Company") to accelerate the development of its novel robot technology to harvest soft fruit and vegetables.

 

Bosch UK will collaborate with Fieldwork's engineers to optimise the Company's soft robotic arms and develop software aimed at reducing the arms' cost and increasing their speed.

 

The objective is to move into full-scale production through the University of Plymouth spin out Fieldwork. The agreement between Fieldwork and Bosch is a significant step forward in the commercialisation of the technology.

 

Frontier IP holds a 26.9 per cent equity stake in Fieldwork, a holding valued at £1,355,000 following the completion in January 2020 of an initial equity funding round for the Company.

 

This agreement between Fieldwork and Bosch represents a further deepening of Frontier IP's relationship with Bosch, a leading global supplier of technology and services that employs approximately 400,000 associates worldwide. Another Group portfolio company Pulsiv Solar is working with Bosch to optimise the design of its energy-efficient solar micro-inverter.

Fieldwork is initially focused on developing robots to harvest raspberries - they are more delicate, more easily damaged than other soft fruits, and grow on bushes with complex foliage and berry distribution. Fieldwork, together with the University of Plymouth, is also developing proof-of-concept robots for other crops following interest from leading multinational agribusinesses.

 

The Company is using the £298,000 raised in the January funding round to accelerate development and scale up of its robotic technology.

 

Work to date has also been supported by a £547,250 Innovate UK grant as part of a £671,484 project to develop the multi-armed robot prototype. Other partners in the project included the University of Plymouth and the National Physical Laboratory.

 

Fieldwork was incorporated to develop and commercialise the work of Dr Martin Stoelen, who splits his work between the University of Plymouth, where he lectures in robotics and leads the Soft and Adaptive Robotics lab, and as an Associate Professor at the Western Norway University of Applied Sciences.

Dr Stoelen has also led projects to develop a cauliflower harvesting robot systems and a tomato picker, a project run in partnership with the Shanghai Jiao Tong University.

 

Jenny Patten, Head of Business Development for Bosch UK, said: "To accelerate the development of technology that has the potential to improve people's quality of life and work, it is incredibly important that organisations - big and small - collaborate, making the best use of skills, knowledge and resources. To this end Bosch UK are very pleased to expand our relationship with Frontier IP and support Fieldwork Robotics in the development of their robotic arm for harvesting soft fruit and vegetables."

 

Vivek Kadal, Head of the Bosch Team working on the development for Fieldwork, said: "It gives Bosch great pleasure to work with companies that pioneer and change the way robotics are being used to simplify human working and this partnership adds to our "invented for Life" objective. Bosch will provide best in class capabilities to enable Fieldwork to commercialise and bring its robots to market."

 

Rui Andres, Fieldwork Robotics Chief Executive Officer, said: "This agreement is the result of several discussions between all the parties and the increasing interest in robotics within Bosch's agribusiness. We are looking forward to working alongside Bosch to further increase the pace of development and preparing the future path of our robots".

 

Neil Crabb, Frontier IP Chief Executive Officer, said: " Industry engagement is a vital part of validating the commercial viability of new technology, so we are delighted to be extending our relationship with Bosch UK. They have provided invaluable support for our work with Pulsiv in optimising its solar microinverter for manufacturability.

 

"Agricultural automation is a long-term trend, but one which has been thrown into sharp relief recently from the impact on human labour of COVID-19, demonstrating the potential value of Fieldwork's technology. We are very much looking forward to working with Bosch UK on this project."

 

  

ENQUIRIES

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers

 

 

 

 

ABout frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

Frontier IP is the commercialisation partner for the University of Plymouth.

ABOUT THE UNIVERSITY OF PLYMOUTH

 

The University of Plymouth is renowned for high quality, internationally-leading education, research and innovation.

 

With a mission to Advance Knowledge and Transform Lives, Plymouth is a *top 50 research university with clusters of world class research across a wide range of disciplines including marine science and engineering, medicine, cybersecurity and psychology. A three-time winner of the Queen's Anniversary Prize for Higher and Further Education, most recently in 2020 in respect of its pioneering research on microplastics pollution in the oceans and its impact on the environment and changing behaviour, the University continues to grow in stature and reputation.

 

It has a strong track record for teaching and learning excellence, and has one of the highest numbers of National Teaching Fellows of any UK university. With over 19,000 students, and a further 9,500 studying for a Plymouth degree at partner institutions in the UK and around the world, and over 135,000 alumni pursuing their chosen careers globally, it has a growing global presence.

http://www.plymouth.ac.uk

* Research Fortnight Research Power League Table 2014.

 

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUORORRVUBRAR
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.